Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,659 | 1,276 | 78.2% |
| Consulting Fee | $5,175 | 1 | 17.9% |
| Travel and Lodging | $728.29 | 4 | 2.5% |
| Education | $332.14 | 15 | 1.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $61.67 | 4 | 0.2% |
| Gift | $12.77 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SK Life Science, Inc. | $8,832 | 129 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $3,882 | 266 | $0 (2024) |
| ABBVIE INC. | $1,243 | 111 | $0 (2024) |
| EMD Serono, Inc. | $932.88 | 45 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $798.62 | 38 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $785.79 | 51 | $0 (2024) |
| Lundbeck LLC | $783.46 | 37 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $741.66 | 32 | $0 (2024) |
| Lilly USA, LLC | $646.12 | 25 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $642.12 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,321 | 273 | SK Life Science, Inc. ($634.17) |
| 2023 | $4,992 | 285 | Teva Pharmaceuticals USA, Inc. ($876.96) |
| 2022 | $3,638 | 199 | Teva Pharmaceuticals USA, Inc. ($927.95) |
| 2021 | $9,262 | 180 | SK Life Science, Inc. ($6,821) |
| 2020 | $1,485 | 111 | Teva Pharmaceuticals USA, Inc. ($536.59) |
| 2019 | $1,277 | 82 | Lilly USA, LLC ($217.69) |
| 2018 | $1,148 | 74 | Abbott Laboratories ($161.38) |
| 2017 | $1,845 | 97 | Allergan Inc. ($318.83) |
All Payment Transactions
1,301 individual payment records from CMS Open Payments — Page 1 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Neurology | ||||||
| 12/19/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $12.75 | General |
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $1.61 | General |
| Category: Neurology | ||||||
| 12/18/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $1.73 | General |
| 12/17/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: PAIN | ||||||
| 12/16/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.55 | General |
| Category: PAIN | ||||||
| 12/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Central Nervous System | ||||||
| 12/12/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Neurology | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.45 | General |
| 12/08/2024 | Ceribell, Inc. | POCKET EEG DEVICE (Device) | Food and Beverage | Cash or cash equivalent | $160.71 | General |
| Category: Neurology | ||||||
| 12/06/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $8.77 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $3.73 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/04/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $120.45 | General |
| Category: Neurology | ||||||
| 12/04/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: Central Nervous System | ||||||
| 12/03/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: NEUROLOGY | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.89 | General |
| Category: NEUROLOGY | ||||||
| 11/20/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Neurology | ||||||
| 11/18/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.99 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,486 | 1,977 | $552,701 | $218,636 |
| 2022 | 14 | 1,495 | 1,893 | $538,840 | $210,535 |
| 2021 | 15 | 1,385 | 1,784 | $496,017 | $194,061 |
| 2020 | 16 | 1,306 | 1,748 | $468,846 | $163,227 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 418 | 567 | $136,080 | $58,455 | 43.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 245 | 351 | $114,075 | $53,402 | 46.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 216 | 265 | $43,725 | $18,792 | 43.0% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 41 | 90 | $62,100 | $15,712 | 25.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 110 | 110 | $40,150 | $15,046 | 37.5% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 32 | 81 | $18,301 | $10,524 | 57.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 88 | 147 | $23,520 | $10,074 | 42.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 49 | 49 | $22,540 | $9,479 | 42.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 50 | 51 | $22,695 | $7,212 | 31.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 21 | 40 | $19,400 | $7,017 | 36.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 97 | 99 | $18,810 | $4,615 | 24.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 36 | 36 | $14,400 | $3,677 | 25.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 20 | $4,600 | $1,982 | 43.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 15 | 17 | $7,055 | $1,760 | 25.0% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 17 | 17 | $3,400 | $531.30 | 15.6% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2023 | 34 | 37 | $1,850 | $358.85 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 408 | 532 | $127,680 | $55,065 | 43.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 202 | 272 | $88,400 | $40,472 | 45.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 247 | 315 | $51,975 | $22,456 | 43.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 159 | 159 | $58,035 | $22,016 | 37.9% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 47 | 96 | $66,240 | $17,010 | 25.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 57 | 58 | $25,810 | $9,869 | 38.2% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2022 | 43 | 65 | $17,765 | $9,552 | 53.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 51 | 51 | $23,460 | $8,889 | 37.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 24 | 41 | $19,885 | $7,770 | 39.1% |
About Dr. Kirk Levy, MD
Dr. Kirk Levy, MD is a Neurology healthcare provider based in Englewood, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023077393.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kirk Levy, MD has received a total of $28,969 in payments from pharmaceutical and medical device companies, with $5,321 received in 2024. These payments were reported across 1,301 transactions from 84 companies. The most common payment nature is "Food and Beverage" ($22,659).
As a Medicare-enrolled provider, Levy has provided services to 5,672 Medicare beneficiaries, totaling 7,402 services with total Medicare billing of $786,459. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Englewood, NJ
- Active Since 03/23/2006
- Last Updated 08/11/2009
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1023077393
Products in Payments
- XCOPRI (Drug) $7,117
- AJOVY (Biological) $1,413
- AUSTEDO (Drug) $1,266
- Austedo XR (Drug) $1,022
- NUPLAZID (Drug) $798.62
- VYEPTI (Biological) $666.61
- KESIMPTA (Drug) $581.92
- NURTEC ODT (Drug) $545.07
- UBRELVY (Drug) $522.36
- INGREZZA (Drug) $493.39
- EMGALITY (Drug) $492.30
- LUMRYZ (Drug) $484.38
- ZEPOSIA (Drug) $463.92
- Hizentra (Biological) $456.75
- QULIPTA (Drug) $450.03
- Wakix (Drug) $433.64
- Briviact (Drug) $316.37
- WAKIX (Drug) $308.02
- Leqembi (Drug) $303.90
- TYSABRI (Biological) $283.57
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Englewood
Dr. Rajeev Kumar, Md, MD
Neurology — Payments: $1.4M
Dr. Marc Treihaft, Md, MD
Neurology — Payments: $672,184
Beverly Gilder, Md, MD
Neurology — Payments: $666,331
Cori Millen, D.o, D.O
Neurology — Payments: $325,077
Rikki Racela, Md, MD
Neurology — Payments: $134,214
Monique Giroux, Md, MD
Neurology — Payments: $85,901